It’s the most wonderful time of the year! We are delighted to announce 3 exciting new articles have been published featuring Nanolive cell imaging. These articles come from users based in South Korea, China and Poland. Happy holidays!

Elevated CLOCK and BMAL1 contribute to the impairment of aerobic glycolysis from astrocytes in Alzheimer’s disease, by Yoo et al., was published in the International Journal of Molecular Sciences. You can read it here.

Tumor vessel targeted self-assemble nanoparticles for amplification and prediction of the embolization effect in hepatocellular carcinoma, by Wang et al. was published in ACS Nano. You can read it here.

Effects of curcumin based PDT on the viability and the organization of actin in melanotic (A375) and amelanotic melanoma (C32)– in vitro studies, by Szlasa et al., was published in the journal Biomedicine & Pharmacotherapy. You can read it here.

Congratulations to the authors above and to all our clients who have published using Nanolive technology in 2020.

Discover our Scientific Publications page

Read our latest news

Move beyond endpoints with dynamic EC50

May 29, 2026 | News

Discover case study data for a dynamic approach to monitoring EC50 to gain more accurate insights into drug function.

Online walkthrough – Replace fragmented assays: one workflow for cell therapy assessment

May 7, 2026 | News

Get a look into Nanolive’s workflow in this on-demand Online Demo, as our Field Application Specialist, Matthias Schade, guides us through the insights gained from a high content phenotypic screen.